Search Results

Filter
  • 1-10 of  10 results for ""MYC oncogenes""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc.

  • Authors : Boffa LC; SC. Oncologia Medica C, Istituto Nazionale per la Ricerca sul Cancro, IST, Largo R. Benzi, GE 10 Genoa 16132, Italy. ; Cutrona G

Subjects: Genes, myc*; Burkitt Lymphoma/Burkitt Lymphoma/Burkitt Lymphoma/*pathology ; Cell Division/Cell Division/Cell Division/*drug effects

  • Source: Cancer gene therapy [Cancer Gene Ther] 2007 Feb; Vol. 14 (2), pp. 220-6. Date of Electronic Publication: 2006 Oct 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line.

  • Authors : Leonetti C; Experimental Chemotherapy Laboratory, Regina Elena Cancer Institute, 00158 Rome, Italy. ; Biroccio A

Subjects: Oligonucleotides, Antisense*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Genes, myc/Genes, myc/Genes, myc/*genetics

  • Source: Cancer gene therapy [Cancer Gene Ther] 2001 Jun; Vol. 8 (6), pp. 459-68.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903

Record details

×
Academic Journal

A cell surface-displayed anti-c-myc single-chain antibody: new perspectives for the genetic improvement of cellular tumor vaccines.

  • Authors : de Inés C; Recombinant Antibody Group, Experimental Therapy and Diagnosis Programme, German Cancer Research Center, Heidelberg.; Cochlovius B

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*immunology ; Antigens, Surface/Antigens, Surface/Antigens, Surface/*immunology ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*therapeutic use

  • Source: Cancer gene therapy [Cancer Gene Ther] 2000 Sep; Vol. 7 (9), pp. 1257-62.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903

Record details

×
Academic Journal

Ribozyme-mediated suppression of v-myc expression abrogates apoptosis in transformed monocytes.

  • Authors : Dolnikov A; School of Physiology and Pharmacology, University of New South Wales, Kensington, Australia.; King A

Subjects: Apoptosis/Apoptosis/Apoptosis/*physiology ; Gene Expression Regulation, Neoplastic/Gene Expression Regulation, Neoplastic/Gene Expression Regulation, Neoplastic/*genetics ; Genes, myc/Genes, myc/Genes, myc/*genetics

  • Source: Cancer gene therapy [Cancer Gene Ther] 1996 Sep-Oct; Vol. 3 (5), pp. 289-95.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903

Record details

×
Academic Journal

Eighth International Conference on Gene Therapy of Cancer.

Subjects: CANCER treatment; GENE therapy; CYCLOOXYGENASE 2

  • Source: Cancer Gene Therapy; Nov1999 Supplement 6, Vol. 6 Issue 6, pS1-S32, 32p

Record details

×
Academic Journal

c-Myc-induced long noncoding RNA MIRE cooperates with hnRNPK to stabilize ELF2 mRNA and promotes clear cell renal cell carcinogenesis.

  • Authors : Li B; The First Affiliated Hospital of USTC, Hefei National Laboratory for Physical Sciences at Microscale, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, Anhui, China.; Yao B

Subjects: Carcinoma*/Carcinoma*/Carcinoma*/genetics ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/pathology ; Kidney Neoplasms*/Kidney Neoplasms*/Kidney Neoplasms*/pathology

  • Source: Cancer gene therapy [Cancer Gene Ther] 2023 Sep; Vol. 30 (9), pp. 1215-1226. Date of Electronic Publication: 2023 May 29.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer.

  • Authors : Liu W; State Key Laboratory for Functions and Applications of Medicinal Plants/College of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, Guizhou, China.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology; Humans

  • Source: Cancer gene therapy [Cancer Gene Ther] 2022 Nov; Vol. 29 (11), pp. 1590-1599. Date of Electronic Publication: 2022 Apr 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  10 results for ""MYC oncogenes""